CROSSJECT (ALCJ.PA) Fundamental Analysis & Valuation

EPA:ALCJ • FR0011716265

Current stock price

2.005 EUR
-0.04 (-1.96%)
Last:

This ALCJ.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. ALCJ.PA Profitability Analysis

1.1 Basic Checks

  • ALCJ had negative earnings in the past year.
  • ALCJ had a negative operating cash flow in the past year.
  • In the past 5 years ALCJ always reported negative net income.
  • ALCJ had a negative operating cash flow in each of the past 5 years.
ALCJ.PA Yearly Net Income VS EBIT VS OCF VS FCFALCJ.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -2M -4M -6M -8M -10M

1.2 Ratios

  • ALCJ's Return On Assets of -35.89% is on the low side compared to the rest of the industry. ALCJ is outperformed by 80.95% of its industry peers.
  • Looking at the Return On Equity, with a value of -308.38%, ALCJ is doing worse than 85.71% of the companies in the same industry.
Industry RankSector Rank
ROA -35.89%
ROE -308.38%
ROIC N/A
ROA(3y)-34.88%
ROA(5y)-33.65%
ROE(3y)-354.28%
ROE(5y)-361.76%
ROIC(3y)N/A
ROIC(5y)N/A
ALCJ.PA Yearly ROA, ROE, ROICALCJ.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -100 -200 -300 -400 -500

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for ALCJ so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ALCJ.PA Yearly Profit, Operating, Gross MarginsALCJ.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2K -4K -6K -8K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. ALCJ.PA Health Analysis

2.1 Basic Checks

  • ALCJ does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, ALCJ has more shares outstanding
  • Compared to 5 years ago, ALCJ has more shares outstanding
  • ALCJ has a worse debt/assets ratio than last year.
ALCJ.PA Yearly Shares OutstandingALCJ.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M
ALCJ.PA Yearly Total Debt VS Total AssetsALCJ.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M

2.2 Solvency

  • ALCJ has an Altman-Z score of 0.50. This is a bad value and indicates that ALCJ is not financially healthy and even has some risk of bankruptcy.
  • ALCJ has a worse Altman-Z score (0.50) than 73.02% of its industry peers.
  • ALCJ has a Debt/Equity ratio of 2.52. This is a high value indicating a heavy dependency on external financing.
  • With a Debt to Equity ratio value of 2.52, ALCJ is not doing good in the industry: 84.13% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 2.52
Debt/FCF N/A
Altman-Z 0.5
ROIC/WACCN/A
WACC7.45%
ALCJ.PA Yearly LT Debt VS Equity VS FCFALCJ.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M -10M 20M

2.3 Liquidity

  • A Current Ratio of 0.93 indicates that ALCJ may have some problems paying its short term obligations.
  • The Current ratio of ALCJ (0.93) is worse than 84.13% of its industry peers.
  • ALCJ has a Quick Ratio of 0.93. This is a bad value and indicates that ALCJ is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 0.59, ALCJ is doing worse than 82.54% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.93
Quick Ratio 0.59
ALCJ.PA Yearly Current Assets VS Current LiabilitesALCJ.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. ALCJ.PA Growth Analysis

3.1 Past

  • ALCJ shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 13.80%, which is quite good.
  • The Revenue for ALCJ has decreased by -100.00% in the past year. This is quite bad
EPS 1Y (TTM)13.8%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%37.07%
Revenue 1Y (TTM)-100%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • ALCJ is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 57.55% yearly.
  • The Revenue is expected to grow by 81.52% on average over the next years. This is a very strong growth
EPS Next Y153.27%
EPS Next 2Y84.31%
EPS Next 3Y57.55%
EPS Next 5YN/A
Revenue Next Year252.41%
Revenue Next 2Y109.17%
Revenue Next 3Y74.23%
Revenue Next 5Y81.52%

3.3 Evolution

ALCJ.PA Yearly Revenue VS EstimatesALCJ.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 20M 40M 60M 80M
ALCJ.PA Yearly EPS VS EstimatesALCJ.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -0.5

More info and screens

Find the best growth stocksShow best growing peers

4

4. ALCJ.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for ALCJ. In the last year negative earnings were reported.
  • ALCJ is valuated cheaply with a Price/Forward Earnings ratio of 5.54.
  • Based on the Price/Forward Earnings ratio, ALCJ is valued cheaply inside the industry as 96.83% of the companies are valued more expensively.
  • When comparing the Price/Forward Earnings ratio of ALCJ to the average of the S&P500 Index (23.10), we can say ALCJ is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 5.54
ALCJ.PA Price Earnings VS Forward Price EarningsALCJ.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALCJ.PA Per share dataALCJ.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 -0.1 0.2 -0.2 0.3

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as ALCJ's earnings are expected to grow with 57.55% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y84.31%
EPS Next 3Y57.55%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ALCJ.PA Dividend Analysis

5.1 Amount

  • ALCJ does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ALCJ.PA Fundamentals: All Metrics, Ratios and Statistics

CROSSJECT

EPA:ALCJ (4/7/2026, 7:00:00 PM)

2.005

-0.04 (-1.96%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)03-25
Earnings (Next)N/A
Inst Owners0.32%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap105.94M
Revenue(TTM)N/A
Net Income(TTM)-11.26M
Analysts86
Price Target4.11 (104.99%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)6.14%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)51.69%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-33.33%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 5.54
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 29.01
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.23
EYN/A
EPS(NY)0.36
Fwd EY18.06%
FCF(TTM)-0.18
FCFYN/A
OCF(TTM)-0.11
OCFYN/A
SpS0
BVpS0.07
TBVpS-0.1
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -35.89%
ROE -308.38%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-34.88%
ROA(5y)-33.65%
ROE(3y)-354.28%
ROE(5y)-361.76%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 2.52
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 60.88%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.93
Quick Ratio 0.59
Altman-Z 0.5
F-Score3
WACC7.45%
ROIC/WACCN/A
Cap/Depr(3y)131.18%
Cap/Depr(5y)130.12%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)13.8%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%37.07%
EPS Next Y153.27%
EPS Next 2Y84.31%
EPS Next 3Y57.55%
EPS Next 5YN/A
Revenue 1Y (TTM)-100%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year252.41%
Revenue Next 2Y109.17%
Revenue Next 3Y74.23%
Revenue Next 5Y81.52%
EBIT growth 1Y5.06%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year190.2%
EBIT Next 3Y71.66%
EBIT Next 5YN/A
FCF growth 1Y20.62%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-66.35%
OCF growth 3YN/A
OCF growth 5YN/A

CROSSJECT / ALCJ.PA Fundamental Analysis FAQ

What is the fundamental rating for ALCJ stock?

ChartMill assigns a fundamental rating of 1 / 10 to ALCJ.PA.


Can you provide the valuation status for CROSSJECT?

ChartMill assigns a valuation rating of 4 / 10 to CROSSJECT (ALCJ.PA). This can be considered as Fairly Valued.


How profitable is CROSSJECT (ALCJ.PA) stock?

CROSSJECT (ALCJ.PA) has a profitability rating of 0 / 10.